학술논문

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
Document Type
Artikel
Source
Trials. 20(1):263
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1745-6215